Healthcare companies are returning COVID-19 relief funds

Some major healthcare companies, including DaVita, Cigna, Encompass, CVS Health and Walmart, are sending back federal aid funding they received that was intended to help hospitals and healthcare providers during the COVID-19 pandemic.

These companies each received millions in funding and were among 500,000 providers who received the first chunk of relief funds, Business Insider reported. The Trump administration sent out $30 billion directly to companies that had recently billed Medicare to get relief out there quickly, and health agencies eventually released guidance on how healthcare agencies could accept the funding.

CVS Health previously announced it was returning $43 million in federal aid that it had received as part of the CARES Act Provider Relief Fund.

Encompass, a provider that specializes in home-based care, said it won’t accept the $237 million it received. Cigna, one of the nation’s largest health insurance companies, is returning $41 million in federal funds from its Accredo business. DaVita, even while facing losses, is returning $240 million in relief funds.

See the full story below:

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

Given the precarious excitement of the moment—or is it exciting precarity?—policymakers and healthcare leaders must set directives guiding not only what to do with AI but also when to do it. 

The final list also included diabetes drugs sold by Boehringer Ingelheim and Merck. The first round of drug price negotiations reduced the Medicare prices for 10 popular drugs by up to 79%. 

HHS has thought through the ways AI can and should become an integral part of healthcare, human services and public health. Last Friday—possibly just days ahead of seating a new secretary—the agency released a detailed plan for getting there from here.